472 filings
Page 13 of 24
6-K
6ltjx
14 May 20
Chi-Med Highlights Clinical Data to be Presented at the Upcoming ASCO20 Virtual Scientific Program
6:22am
6-K
ixljl53g wlbtdlwx
11 May 20
Chi-Med to Attend Upcoming Investor Conferences
6:42am
20-F/A
6341il63gs
29 Apr 20
Annual report (foreign) (amended)
7:47am
6-K
s95kchz0x
29 Apr 20
Current report (foreign)
6:58am
6-K
i98og7
27 Apr 20
Results of Annual General Meeting
9:23am
6-K
wcuix6y2l5rauc
22 Apr 20
Chi-Med Highlights Presentations of Surufatinib at the Upcoming AACR Virtual Annual Meetings
6:23am
6-K
ysj xyqnm9j
21 Apr 20
Grant of Awards under Long Term Incentive Plan and Share Options under Share Option Scheme
6:45am
6-K
gkzg5f25
17 Apr 20
Chi-Med Announces Surufatinib Granted U.S. FDA Fast Track Designations for the Treatment of Both Pancreatic and Non-Pancreatic Neuroendocrine Tumors
6:23am
F-3ASR
grw1wca0szpy13po 1d
6 Apr 20
Automatic shelf registration (foreign)
6:18am
6-K
ax32fba663cwlaivl
31 Mar 20
Current report (foreign)
6:33am
6-K
4rqjkvism98a8
25 Mar 20
2019 Annual Report and Notice of Annual General Meeting
6:53am
UPLOAD
3k6ch99
19 Mar 20
Letter from SEC
12:00am
6-K
srbmp3k0zqgi
9 Mar 20
Vesting of awards under the Long Term Incentive Plan
7:00am
CT ORDER
1vs0j9eurjyk
6 Mar 20
Confidential treatment order
11:01am
6-K
1cpgo7quhu6b1zhfau
3 Mar 20
Chi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical Programs
7:34am
6-K
8ay0 6e0km
25 Feb 20
Current report (foreign)
6:36am
CORRESP
vrl808hao
21 Feb 20
Correspondence with SEC
12:00am
UPLOAD
jzuwcutsrh8q3in clgs
12 Feb 20
Letter from SEC
12:00am
6-K
sxzlre2p
10 Feb 20
Current report (foreign)
6:09am